1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Neuropsychiatric Disorders and Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Drug Treatment 1.2.3 Shock Treatment 1.2.4 Others 1.3 Market by Application 1.3.1 Global Neuropsychiatric Disorders and Treatment Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Research Centres 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Neuropsychiatric Disorders and Treatment Market Perspective (2016-2027) 2.2 Neuropsychiatric Disorders and Treatment Growth Trends by Regions 2.2.1 Neuropsychiatric Disorders and Treatment Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Neuropsychiatric Disorders and Treatment Historic Market Share by Regions (2016-2021) 2.2.3 Neuropsychiatric Disorders and Treatment Forecasted Market Size by Regions (2022-2027) 2.3 Neuropsychiatric Disorders and Treatment Industry Dynamic 2.3.1 Neuropsychiatric Disorders and Treatment Market Trends 2.3.2 Neuropsychiatric Disorders and Treatment Market Drivers 2.3.3 Neuropsychiatric Disorders and Treatment Market Challenges 2.3.4 Neuropsychiatric Disorders and Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Neuropsychiatric Disorders and Treatment Players by Revenue 3.1.1 Global Top Neuropsychiatric Disorders and Treatment Players by Revenue (2016-2021) 3.1.2 Global Neuropsychiatric Disorders and Treatment Revenue Market Share by Players (2016-2021) 3.2 Global Neuropsychiatric Disorders and Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Neuropsychiatric Disorders and Treatment Revenue 3.4 Global Neuropsychiatric Disorders and Treatment Market Concentration Ratio 3.4.1 Global Neuropsychiatric Disorders and Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Neuropsychiatric Disorders and Treatment Revenue in 2020 3.5 Neuropsychiatric Disorders and Treatment Key Players Head office and Area Served 3.6 Key Players Neuropsychiatric Disorders and Treatment Product Solution and Service 3.7 Date of Enter into Neuropsychiatric Disorders and Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Neuropsychiatric Disorders and Treatment Breakdown Data by Type 4.1 Global Neuropsychiatric Disorders and Treatment Historic Market Size by Type (2016-2021) 4.2 Global Neuropsychiatric Disorders and Treatment Forecasted Market Size by Type (2022-2027) 5 Neuropsychiatric Disorders and Treatment Breakdown Data by Application 5.1 Global Neuropsychiatric Disorders and Treatment Historic Market Size by Application (2016-2021) 5.2 Global Neuropsychiatric Disorders and Treatment Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Neuropsychiatric Disorders and Treatment Market Size (2016-2027) 6.2 North America Neuropsychiatric Disorders and Treatment Market Size by Type 6.2.1 North America Neuropsychiatric Disorders and Treatment Market Size by Type (2016-2021) 6.2.2 North America Neuropsychiatric Disorders and Treatment Market Size by Type (2022-2027) 6.2.3 North America Neuropsychiatric Disorders and Treatment Market Size by Type (2016-2027) 6.3 North America Neuropsychiatric Disorders and Treatment Market Size by Application 6.3.1 North America Neuropsychiatric Disorders and Treatment Market Size by Application (2016-2021) 6.3.2 North America Neuropsychiatric Disorders and Treatment Market Size by Application (2022-2027) 6.3.3 North America Neuropsychiatric Disorders and Treatment Market Size by Application (2016-2027) 6.4 North America Neuropsychiatric Disorders and Treatment Market Size by Country 6.4.1 North America Neuropsychiatric Disorders and Treatment Market Size by Country (2016-2021) 6.4.2 North America Neuropsychiatric Disorders and Treatment Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Neuropsychiatric Disorders and Treatment Market Size (2016-2027) 7.2 Europe Neuropsychiatric Disorders and Treatment Market Size by Type 7.2.1 Europe Neuropsychiatric Disorders and Treatment Market Size by Type (2016-2021) 7.2.2 Europe Neuropsychiatric Disorders and Treatment Market Size by Type (2022-2027) 7.2.3 Europe Neuropsychiatric Disorders and Treatment Market Size by Type (2016-2027) 7.3 Europe Neuropsychiatric Disorders and Treatment Market Size by Application 7.3.1 Europe Neuropsychiatric Disorders and Treatment Market Size by Application (2016-2021) 7.3.2 Europe Neuropsychiatric Disorders and Treatment Market Size by Application (2022-2027) 7.3.3 Europe Neuropsychiatric Disorders and Treatment Market Size by Application (2016-2027) 7.4 Europe Neuropsychiatric Disorders and Treatment Market Size by Country 7.4.1 Europe Neuropsychiatric Disorders and Treatment Market Size by Country (2016-2021) 7.4.2 Europe Neuropsychiatric Disorders and Treatment Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size (2016-2027) 8.2 Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Type 8.2.1 Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Type (2016-2027) 8.3 Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Application 8.3.1 Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Application (2016-2027) 8.4 Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Region 8.4.1 Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Neuropsychiatric Disorders and Treatment Market Size (2016-2027) 9.2 Latin America Neuropsychiatric Disorders and Treatment Market Size by Type 9.2.1 Latin America Neuropsychiatric Disorders and Treatment Market Size by Type (2016-2021) 9.2.2 Latin America Neuropsychiatric Disorders and Treatment Market Size by Type (2022-2027) 9.2.3 Latin America Neuropsychiatric Disorders and Treatment Market Size by Type (2016-2027) 9.3 Latin America Neuropsychiatric Disorders and Treatment Market Size by Application 9.3.1 Latin America Neuropsychiatric Disorders and Treatment Market Size by Application (2016-2021) 9.3.2 Latin America Neuropsychiatric Disorders and Treatment Market Size by Application (2022-2027) 9.3.3 Latin America Neuropsychiatric Disorders and Treatment Market Size by Application (2016-2027) 9.4 Latin America Neuropsychiatric Disorders and Treatment Market Size by Country 9.4.1 Latin America Neuropsychiatric Disorders and Treatment Market Size by Country (2016-2021) 9.4.2 Latin America Neuropsychiatric Disorders and Treatment Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size (2016-2027) 10.2 Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Type 10.2.1 Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Type (2016-2027) 10.3 Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Application 10.3.1 Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Application (2016-2027) 10.4 Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Country 10.4.1 Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Astrazeneca 11.1.1 Astrazeneca Company Details 11.1.2 Astrazeneca Business Overview 11.1.3 Astrazeneca Neuropsychiatric Disorders and Treatment Introduction 11.1.4 Astrazeneca Revenue in Neuropsychiatric Disorders and Treatment Business (2016-2021) 11.1.5 Astrazeneca Recent Development 11.2 Glaxosmithkline 11.2.1 Glaxosmithkline Company Details 11.2.2 Glaxosmithkline Business Overview 11.2.3 Glaxosmithkline Neuropsychiatric Disorders and Treatment Introduction 11.2.4 Glaxosmithkline Revenue in Neuropsychiatric Disorders and Treatment Business (2016-2021) 11.2.5 Glaxosmithkline Recent Development 11.3 Universal Health Services 11.3.1 Universal Health Services Company Details 11.3.2 Universal Health Services Business Overview 11.3.3 Universal Health Services Neuropsychiatric Disorders and Treatment Introduction 11.3.4 Universal Health Services Revenue in Neuropsychiatric Disorders and Treatment Business (2016-2021) 11.3.5 Universal Health Services Recent Development 11.4 Boehringer Ingelheim 11.4.1 Boehringer Ingelheim Company Details 11.4.2 Boehringer Ingelheim Business Overview 11.4.3 Boehringer Ingelheim Neuropsychiatric Disorders and Treatment Introduction 11.4.4 Boehringer Ingelheim Revenue in Neuropsychiatric Disorders and Treatment Business (2016-2021) 11.4.5 Boehringer Ingelheim Recent Development 11.5 Eli Lilly 11.5.1 Eli Lilly Company Details 11.5.2 Eli Lilly Business Overview 11.5.3 Eli Lilly Neuropsychiatric Disorders and Treatment Introduction 11.5.4 Eli Lilly Revenue in Neuropsychiatric Disorders and Treatment Business (2016-2021) 11.5.5 Eli Lilly Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Neuropsychiatric Disorders and Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Drug Treatment Table 3. Key Players of Shock Treatment Table 4. Key Players of Others Table 5. Global Neuropsychiatric Disorders and Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Neuropsychiatric Disorders and Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Neuropsychiatric Disorders and Treatment Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Neuropsychiatric Disorders and Treatment Market Share by Regions (2016-2021) Table 9. Global Neuropsychiatric Disorders and Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Neuropsychiatric Disorders and Treatment Market Share by Regions (2022-2027) Table 11. Neuropsychiatric Disorders and Treatment Market Trends Table 12. Neuropsychiatric Disorders and Treatment Market Drivers Table 13. Neuropsychiatric Disorders and Treatment Market Challenges Table 14. Neuropsychiatric Disorders and Treatment Market Restraints Table 15. Global Neuropsychiatric Disorders and Treatment Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Neuropsychiatric Disorders and Treatment Market Share by Players (2016-2021) Table 17. Global Top Neuropsychiatric Disorders and Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuropsychiatric Disorders and Treatment as of 2020) Table 18. Ranking of Global Top Neuropsychiatric Disorders and Treatment Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Neuropsychiatric Disorders and Treatment Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Neuropsychiatric Disorders and Treatment Product Solution and Service Table 22. Date of Enter into Neuropsychiatric Disorders and Treatment Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Neuropsychiatric Disorders and Treatment Market Size by Type (2016-2021) (US$ Million) Table 25. Global Neuropsychiatric Disorders and Treatment Revenue Market Share by Type (2016-2021) Table 26. Global Neuropsychiatric Disorders and Treatment Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Neuropsychiatric Disorders and Treatment Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Neuropsychiatric Disorders and Treatment Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Neuropsychiatric Disorders and Treatment Revenue Market Share by Application (2016-2021) Table 30. Global Neuropsychiatric Disorders and Treatment Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Neuropsychiatric Disorders and Treatment Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Neuropsychiatric Disorders and Treatment Market Size by Type (2016-2021) (US$ Million) Table 33. North America Neuropsychiatric Disorders and Treatment Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Neuropsychiatric Disorders and Treatment Market Size by Application (2016-2021) (US$ Million) Table 35. North America Neuropsychiatric Disorders and Treatment Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Neuropsychiatric Disorders and Treatment Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Neuropsychiatric Disorders and Treatment Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Neuropsychiatric Disorders and Treatment Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Neuropsychiatric Disorders and Treatment Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Neuropsychiatric Disorders and Treatment Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Neuropsychiatric Disorders and Treatment Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Neuropsychiatric Disorders and Treatment Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Neuropsychiatric Disorders and Treatment Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Neuropsychiatric Disorders and Treatment Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Neuropsychiatric Disorders and Treatment Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Neuropsychiatric Disorders and Treatment Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Neuropsychiatric Disorders and Treatment Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Neuropsychiatric Disorders and Treatment Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Neuropsychiatric Disorders and Treatment Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size by Country (2022-2027) & (US$ Million) Table 62. Astrazeneca Company Details Table 63. Astrazeneca Business Overview Table 64. Astrazeneca Neuropsychiatric Disorders and Treatment Product Table 65. Astrazeneca Revenue in Neuropsychiatric Disorders and Treatment Business (2016-2021) & (US$ Million) Table 66. Astrazeneca Recent Development Table 67. Glaxosmithkline Company Details Table 68. Glaxosmithkline Business Overview Table 69. Glaxosmithkline Neuropsychiatric Disorders and Treatment Product Table 70. Glaxosmithkline Revenue in Neuropsychiatric Disorders and Treatment Business (2016-2021) & (US$ Million) Table 71. Glaxosmithkline Recent Development Table 72. Universal Health Services Company Details Table 73. Universal Health Services Business Overview Table 74. Universal Health Services Neuropsychiatric Disorders and Treatment Product Table 75. Universal Health Services Revenue in Neuropsychiatric Disorders and Treatment Business (2016-2021) & (US$ Million) Table 76. Universal Health Services Recent Development Table 77. Boehringer Ingelheim Company Details Table 78. Boehringer Ingelheim Business Overview Table 79. Boehringer Ingelheim Neuropsychiatric Disorders and Treatment Product Table 80. Boehringer Ingelheim Revenue in Neuropsychiatric Disorders and Treatment Business (2016-2021) & (US$ Million) Table 81. Boehringer Ingelheim Recent Development Table 82. Eli Lilly Company Details Table 83. Eli Lilly Business Overview Table 84. Eli Lilly Neuropsychiatric Disorders and Treatment Product Table 85. Eli Lilly Revenue in Neuropsychiatric Disorders and Treatment Business (2016-2021) & (US$ Million) Table 86. Eli Lilly Recent Development Table 87. Research Programs/Design for This Report Table 88. Key Data Information from Secondary Sources Table 89. Key Data Information from Primary Sources List of Figures Figure 1. Global Neuropsychiatric Disorders and Treatment Market Share by Type: 2020 VS 2027 Figure 2. Drug Treatment Features Figure 3. Shock Treatment Features Figure 4. Others Features Figure 5. Global Neuropsychiatric Disorders and Treatment Market Share by Application: 2020 VS 2027 Figure 6. Hospitals Case Studies Figure 7. Clinics Case Studies Figure 8. Research Centres Case Studies Figure 9. Neuropsychiatric Disorders and Treatment Report Years Considered Figure 10. Global Neuropsychiatric Disorders and Treatment Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global Neuropsychiatric Disorders and Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Neuropsychiatric Disorders and Treatment Market Share by Regions: 2020 VS 2027 Figure 13. Global Neuropsychiatric Disorders and Treatment Market Share by Regions (2022-2027) Figure 14. Global Neuropsychiatric Disorders and Treatment Market Share by Players in 2020 Figure 15. Global Top Neuropsychiatric Disorders and Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuropsychiatric Disorders and Treatment as of 2020 Figure 16. The Top 10 and 5 Players Market Share by Neuropsychiatric Disorders and Treatment Revenue in 2020 Figure 17. Global Neuropsychiatric Disorders and Treatment Revenue Market Share by Type (2016-2021) Figure 18. Global Neuropsychiatric Disorders and Treatment Revenue Market Share by Type (2022-2027) Figure 19. North America Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America Neuropsychiatric Disorders and Treatment Market Share by Type (2016-2027) Figure 21. North America Neuropsychiatric Disorders and Treatment Market Share by Application (2016-2027) Figure 22. North America Neuropsychiatric Disorders and Treatment Market Share by Country (2016-2027) Figure 23. United States Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Neuropsychiatric Disorders and Treatment Market Share by Type (2016-2027) Figure 27. Europe Neuropsychiatric Disorders and Treatment Market Share by Application (2016-2027) Figure 28. Europe Neuropsychiatric Disorders and Treatment Market Share by Country (2016-2027) Figure 29. Germany Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Neuropsychiatric Disorders and Treatment Market Share by Type (2016-2027) Figure 37. Asia-Pacific Neuropsychiatric Disorders and Treatment Market Share by Application (2016-2027) Figure 38. Asia-Pacific Neuropsychiatric Disorders and Treatment Market Share by Region (2016-2027) Figure 39. China Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Neuropsychiatric Disorders and Treatment Market Share by Type (2016-2027) Figure 47. Latin America Neuropsychiatric Disorders and Treatment Market Share by Application (2016-2027) Figure 48. Latin America Neuropsychiatric Disorders and Treatment Market Share by Country (2016-2027) Figure 49. Mexico Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Neuropsychiatric Disorders and Treatment Market Share by Type (2016-2027) Figure 53. Middle East & Africa Neuropsychiatric Disorders and Treatment Market Share by Application (2016-2027) Figure 54. Middle East & Africa Neuropsychiatric Disorders and Treatment Market Share by Country (2016-2027) Figure 55. Turkey Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE Neuropsychiatric Disorders and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Astrazeneca Revenue Growth Rate in Neuropsychiatric Disorders and Treatment Business (2016-2021) Figure 59. Glaxosmithkline Revenue Growth Rate in Neuropsychiatric Disorders and Treatment Business (2016-2021) Figure 60. Universal Health Services Revenue Growth Rate in Neuropsychiatric Disorders and Treatment Business (2016-2021) Figure 61. Boehringer Ingelheim Revenue Growth Rate in Neuropsychiatric Disorders and Treatment Business (2016-2021) Figure 62. Eli Lilly Revenue Growth Rate in Neuropsychiatric Disorders and Treatment Business (2016-2021) Figure 63. Bottom-up and Top-down Approaches for This Report Figure 64. Data Triangulation Figure 65. Key Executives Interviewed

Astrazeneca Glaxosmithkline Universal Health Services Boehringer Ingelheim Eli Lilly